A case of EUS-guided FNA–related pancreatic cancer metastasis to the stomach

Ahmed, Kashif; Sussman, Jeffrey J.; Wang, Jiang; Schmulewitz, Nathan

doi:10.1016/j.gie.2010.10.008

Cited by 72 publications

(48 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The concerns over cancer cell seeding along the needle track or within the peritoneum caused by EUS-FNA of pancreatic lesions have arisen from numerous case reports 4 5 6 14 15. In a retrospective study of 175 patients with intraductal papillary mucinous neoplasm, EUS-FNA did not increase the frequency of postoperative peritoneal seeding 16.…”

Section: Discussionmentioning

confidence: 99%

Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer

Ngamruengphong

Swanson

Shah

et al. 2015

Gut

100

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer

Ngamruengphong

Swanson

Shah

et al. 2015

Gut

100

View full text Add to dashboard Cite

show abstract

“…The complications of EUS-guided sampling of the masses of pancreas include hemorrhage (0.5-2% of the cases) (24,26,27,39,40) and tumor seeding in other parts of the abdomen whose risk is very low (41)(42)(43). The study conducted by Khashab et al (44) indicated that EUS-FNA by flow cytometry was preferred to EUSFNA without flow cytometry in the assessment of 16 patients suspected to primary pancreas lymphoma.…”

Section: Eusmentioning

confidence: 99%

Primary pancreatic lymphoma: what we need to know

Rad

Khafaf

Alizadeh

2017

J. Gastrointest. Oncol.

View full text Add to dashboard Cite

Hodgkin's lymphoma is a group of malignant lymphoid which involve various organs including gastrointestinal tract. Stomach and small intestine are commonly involved more; however, pancreas can be primarily involved as well. The secondary involvement of pancreas caused by Hodgkin's lymphoma is more prevalent than the primarily involvement (1 .25-2.2% .<1%). Primary pancreatic lymphomas (PPLs) consist of 1-2% of all lymphoma outside nods. The symptoms and findings of PPL imaging can be akin to that of pancreas adenocarcinoma and differentiating them is difficult without examining the tissue sample. The prognosis and treatment of PPL are different from those of adenocarcinoma and due to the superior prognosis of PPL compared to pancreas adenocarcinoma, the proper diagnosis of the disease is important.

show abstract

“…However, some surgeons do not prefer preoperative EUS-FNA, due to concerns of tumor cell seeding along the needle track or at the peritoneum. Indeed, there are previous reports of tumor seeding at the gastric wall due to the needle track (9)(10)(11)(12)(13)(14)(15). In our study, the relapse rates at peripancreatic tissue and/or the peritoneum were similar between the EUS-FNA (36-month: 17.8%) and the non-EUS-FNA (36-month: 12.8%; p=0.641) groups after adjusting for competing death events, although one patient (1.9%) likely developed needle track seeding at the gastric wall.…”

Section: Discussion Discussionmentioning

confidence: 99%

Comparison of Diagnostic Sensitivities for Resectable Pancreatic Adenocarcinoma Between Endoscopic Ultrasound-guided Fine-needle Aspiration and Blinded Computed Tomography

Ito¹,

Kawaguchi²,

Okura³

et al. 2018

SGO

View full text Add to dashboard Cite

Background: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is performed for diagnosing pancreatic lesions. As EUS-FNA can develop needle track seeding, its use for radiographically-diagnosed pancreatic malignancy remains controversial. We investigated a useful setting of EUS-FNA for resectable pancreatic adenocarcinoma by comparing the diagnostic sensitivity between EUS-FNA and contrast enhanced-computed tomography (CT), and by evaluating the short-and long-term outcomes. Methods: Between January 2012 and March 2015, 107 consecutive patients underwent resection for pancreatic adenocarcinoma were evaluated retrospectively. Short-and longterm outcomes were compared between patients receiving EUS-FNA and patients who did not. Results: EUS-FNA was performed for 52 patients (48.6%).Diagnostic sensitivity of EUS-FNA (90.4%) was significantly higher than for blinded CT(69.2%) (p=0.021). EUS-FNA accurately diagnosed pancreatic adenocarcinoma in 16 of 16 (100%) patients who had small tumor diameter, autoimmune pancreatitis, or IPMN-related tumor although they were not correctly diagnosed by radiographic findings. In particular, the sensitivity of EUS-FNA was approximately 90%, irrespective of tumor size, while that for blinded CT was low in cases with a small tumor size (46% for TS1 tumor). Preoperative EUS-FNA was not associated with overall survival (p=0.958), recurrence-free survival (p=0.357), and relapse rate at peripancreatic tissue and/or peritoneum(p=0.641). Conclusion: EUS-FNA is particularly useful for diagnosing small pancreatic ductal adenocarcinoma, adenocarcinoma with pancreatitis or IPMN-related adenocarcinoma, providing high diagnostic sensitivity and acceptable prognostic outcomes.

show abstract

A case of EUS-guided FNA–related pancreatic cancer metastasis to the stomach

Cited by 72 publications

References 8 publications

Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer

Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer

Primary pancreatic lymphoma: what we need to know

Comparison of Diagnostic Sensitivities for Resectable Pancreatic Adenocarcinoma Between Endoscopic Ultrasound-guided Fine-needle Aspiration and Blinded Computed Tomography

Contact Info

Product

Resources

About